Showing results (2641-2650 of 5,969) with videos related to

Sort By:
Pageof 597
Endocrine|June 21, 2025
Differences in autoimmune thyroid diseases between females and males: the result of a complex interconnection of factorsFiammetta Battheu, Cristina Clausi, Simona Censi, et al.
Endocrine|June 21, 2025
Knowledge, attitudes, and practices of healthcare professionals regarding medical nutrition therapy for type 2 diabetes: a multicenter cross-sectional studyXiaohong Xu, Juan Yuan, Man Zhan, et al.
Endocrine|December 24, 2024
Pediatrics cascade screening in inherited dyslipidemias: a lipoprotein apheresis center experienceFrancesco Sbrana, Beatrice Dal Pino, Carmen Corciulo, et al.
Endocrine|December 20, 2024
Primary tumor resection with or without neck lymph node dissection as a viable initial therapy for medullary thyroid carcinoma with distant metastasisZiyi Chen, Wangwang Qiu, Ting Yan, et al.
Endocrine|January 1, 2025
Data-driven cluster analysis of lipids, inflammation, and aging in relation to new-onset type 2 diabetes mellitusHa-Eun Ryu, Seok-Jae Heo, Jong Hee Lee, et al.
Endocrine|December 26, 2024
Relation of serum irisin levels with adiposity, components of metabolic syndrome and carotid intima media thickness in prepubertal children with obesity: a cross-sectional studyD Herouvi, E A Vlachopapadopoulou, M Vakaki, et al.
Endocrine|December 31, 2024
Increased ferritin with contraceptives containing ethinyl estradiol drospirenone in polycystic ovary syndrome: a paradox of iron storage and iron deficiencyNaile Gokkaya, Gizem Gecmez, Serhat Ozcelik, et al.
Endocrine|December 20, 2024
The relationship between excessive iodine during pregnancy and adverse pregnancy complicationsShasha Li, Hongying Zha, Yumeng Cui, et al.
Endocrine|February 11, 2025
Expanding the phenotype of multiple endocrine neoplasia type 5 (MEN5): Pituitary gigantism, myelolipoma and familial pheochromocytoma due to a germline pathogenic MAX variantAdnan Haider, Jesse Sundar, Albert Beckers, et al.
Endocrine|February 12, 2025
The monocyte/HDLc ratio and LDLc are two independent predictors of the response of Graves' ophthalmopathy patients to parenteral glucocorticoidsRosario Le Moli, Adriano Naselli, Tommaso Piticchio, et al.
Pageof 597